Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research Genetics Investing
Helius Medical Technologies Announces Launch of Sixth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial Medical Device Investing
Obalon Announces Initial Commercial Patient Placements of the First and Only Swallowable, FDA-Approved Balloon System for Weight Loss Medical Device Investing
Aurora Spine’s Patent Related to Its Polyaxial ZIP® ISP Allowed by the United States Patent Office Medical Device Investing
Tabula Rasa HealthCare Signs Three Year Agreement to Provide Medication Care Management for Multi-State PACE Sponsor Cloud Investing
Pluristem Completes Patient Enrollment in a Large Multinational Phase II Trial in Intermittent Claudication Biotech Investing
Cellect Receives Patent Notice of Allowance from US Patent & Trademark Office Protecting Company’s Technology in Multiple Key Indications Biotech Investing
BioPharmX Data Suggest Anti-Inflammatory Activity of BPX-01 Topical Minocycline Gel Life Science Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
